|
1.
|
Cheuk DK and Wong V: Attention-deficit
hyperactivity disorder and blood mercury level: a case-control
study in Chinese children. Neuropediatrics. 37:234–240. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Sheehan K, Hawi Z, Gill M and Kent L: No
association between TPH2 gene polymorphisms and ADHD in a UK
sample. Neurosci Lett. 412:105–107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Gornick MC, Addington A, Shaw P, et al:
Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele
with children with attention-deficit/hyperactivity disorder (ADHD):
an update. Am J Med Genet B Neuropsychiatr Genet. 144B:379–382.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Thapar A, O’Donovan M and Owen MJ: The
genetics of attention deficit hyperactivity disorder. Hum Mol
Genet. 14:R275–R282. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Tsai SJ: Attention-deficit hyperactivity
disorder may be associated with decreased central brain-derived
neurotrophic factor activity: clinical and therapeutic
implications. Med Hypotheses. 68:896–899. 2007. View Article : Google Scholar
|
|
6.
|
Rowland AS, Lesesne CA and Abramowitz AJ:
The epidemiology of attention-deficit/hyperactivity disorder
(ADHD): a public health view. Ment Retard Dev Disabil Res Rev.
8:162–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Gizer IR, Ficks C and Waldman ID:
Candidate gene studies of ADHD: a meta-analytic review. Hum Genet.
126:51–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Guan L, Wang B, Chen Y, et al: A
high-density single-nucleotide polymorphism screen of 23 candidate
genes in attention deficit hyperactivity disorder: suggesting
multiple susceptibility genes among Chinese Han population. Mol
Psychiatry. 14:546–554. 2009. View Article : Google Scholar
|
|
9.
|
Hesse S, Ballaschke O, Barthel H and Sabri
O: Dopamine transporter imaging in adult patients with
attention-deficit/hyperactivity disorder. Psychiatry Res.
171:120–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kopeckova M, Paclt I, Petrasek J, Pacltova
D, Malikova M and Zagatova V: Some ADHD polymorphisms (in genes
DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects
6–10 age. Neuro Endocrinol Lett. 29:246–251. 2008.PubMed/NCBI
|
|
11.
|
Nyman ES, Ogdie MN, Loukola A, et al: ADHD
candidate gene study in a population-based birth cohort:
association with DBH and DRD2. J Am Acad Child Adolesc Psychiatry.
46:1614–1621. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Barkley RA, Smith KM, Fischer M and Navia
B: An examination of the behavioral and neuropsychological
correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH
TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children
followed to adulthood. Am J Med Genet B Neuropsychiatr Genet.
141B:487–498. 2006.PubMed/NCBI
|
|
13.
|
Kopeckova M, Paclt I and Goetz P:
Polymorphisms and low plasma activity of dopamine-beta-hydroxylase
in ADHD children. Neuro Endocrinol Lett. 27:748–754.
2006.PubMed/NCBI
|
|
14.
|
Roman T, Schmitz M, Polanczyk GV, Eizirik
M, Rohde LA and Hutz MH: Further evidence for the association
between attention-deficit/hyperactivity disorder and the
dopamine-beta-hydroxylase gene. Am J Med Genet. 114:154–158. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Brookes KJ, Mill J, Guindalini C, et al: A
common haplotype of the dopamine transporter gene associated with
attention-deficit/hyperactivity disorder and interacting with
maternal use of alcohol during pregnancy. Arch Gen Psychiatry.
63:74–81. 2006. View Article : Google Scholar
|
|
16.
|
Krause J: SPECT and PET of the dopamine
transporter in attention-deficit/hyperactivity disorder. Expert Rev
Neurother. 8:611–625. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Qian Q, Wang Y, Zhou R, Yang L and Faraone
SV: Family-based and case-control association studies of DRD4 and
DAT1 polymorphisms in Chinese attention deficit hyperactivity
disorder patients suggest long repeats contribute to genetic risk
for the disorder. Am J Med Genet B Neuropsychiatr Genet.
128B:84–89. 2004. View Article : Google Scholar
|
|
18.
|
Wei J, Xu HM, Ramchand CN and Hemmings GP:
Is the polymorphic microsatellite repeat of the dopamine
beta-hydroxylase gene associated with biochemical variability of
the catecholamine pathway in schizophrenia? Biol Psychiatry.
41:762–767. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Galvin M, Ten Eyck R, Shekhar A, et al:
Serum dopamine beta hydroxylase and maltreatment in psychiatrically
hospitalized boys. Child Abuse Negl. 19:821–832. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Nagatsu T and Udenfriend S: Photometric
assay of dopamine – hydroxylase activity in human blood. Clin Chem.
18:980–983. 1972.
|
|
21.
|
Kopeckova M, Paclt I and Goetz P:
Polymorphisms of dopamine-beta-hydroxylase in ADHD children. Folia
Biol. 52:194–201. 2006.PubMed/NCBI
|
|
22.
|
Hartman BK: Immunofluorescence of
dopamine-hydroxylase. Application of improved methodology to the
localization of the peripheral and central noradrenergic nervous
system. J Histochem Cytochem. 21:312–332. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Smith KM, Daly M, Fischer M, et al:
Association of the dopamine beta hydroxylase gene with attention
deficit hyperactivity disorder: genetic analysis of the Milwaukee
longitudinal study. Am J Med Genet B Neuropsychiatr Genet.
119B:77–85. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Parsian A and Zhang ZH: Human dopamine
transporter gene polymorphism (VNTR) and alcoholism. Am J Med
Genet. 74:480–482. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Prince J: Catecholamine dysfunction in
attention-deficit/hyperactivity disorder: an update. J Clin
Psychopharmacol. 28:S39–S45. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Jucaite A, Fernell E, Halldin C, Forssberg
H and Farde L: Reduced midbrain dopamine transporter binding in
male adolescents with attention-deficit/hyperactivity disorder:
association between striatal dopamine markers and motor
hyperactivity. Biol Psychiatry. 57:229–238. 2005. View Article : Google Scholar
|
|
27.
|
Spencer TJ, Biederman J, Madras BK, et al:
Further evidence of dopamine transporter dysregulation in ADHD: a
controlled PET imaging study using altropane. Biol Psychiatry.
62:1059–1061. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Cook EH Jr, Stein MA, Krasowski MD, et al:
Association of attention-deficit disorder and the dopamine
transporter gene. Am J Hum Genet. 56:993–998. 1995.PubMed/NCBI
|
|
29.
|
Drtilkova I, Sery O, Theiner P, et al:
Clinical and molecular-genetic markers of ADHD in children. Neuro
Endocrinol Lett. 29:320–327. 2008.PubMed/NCBI
|
|
30.
|
Hawi Z, Segurado R, Conroy J, et al:
Preferential transmission of paternal alleles at risk genes in
attention-deficit/hyperactivity disorder. Am J Hum Genet.
77:958–965. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Faraone SV and Khan SA: Candidate gene
studies of attention-deficit/hyperactivity disorder. J Clin
Psychiatry. 67(Suppl 8): 13–20. 2006.
|
|
32.
|
Yang XM, Wang SH, Yang YD, et al: A
dopaminergic projection from the dorsal raphe nucleus to the inner
ear. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 41:857–860.
2006.PubMed/NCBI
|
|
33.
|
O’Connor DT, Levine GL and Frigon RP:
Homologous radio-immunoassay of human plasma
dopamine-beta-hydroxylase: analysis of homospecific activity,
circulating plasma pool and intergroup differences based on race,
blood pressure and cardiac function. J Hypertens. 1:227–233.
1983.
|
|
34.
|
Galvin MR, Stilwell BM, Shekhar A, Kopta
SM and Goldfarb SM: Maltreatment, conscience functioning and
dopamine beta hydroxylase in emotionally disturbed boys. Child
Abuse Negl. 21:83–92. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Bhaduri N, Sarkar K, Sinha S,
Chattopadhyay A and Mukhopadhyay K: Study on DBH genetic
polymorphisms and plasma activity in attention deficit
hyperactivity disorder patients from Eastern India. Cell Mol
Neurobiol. 30:265–274. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Genro JP, Polanczyk GV, Zeni C, et al: A
common haplotype at the dopamine transporter gene 5’ region is
associated with attention-deficit/hyperactivity disorder. Am J Med
Genet B Neuropsychiatr Genet. 147B:1568–1575. 2008.
|
|
37.
|
Johansson S, Halleland H, Halmoy A, et al:
Genetic analyses of dopamine related genes in adult ADHD patients
suggest an association with the DRD5-microsatellite repeat, but not
with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet.
147B:1470–1475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Langley K, Turic D, Peirce TR, et al: No
support for association between the dopamine transporter (DAT1)
gene and ADHD. Am J Med Genet B Neuropsychiatr Genet. 139B:7–10.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Swanson JM, Kinsbourne M, Nigg J, et al:
Etiologic subtypes of attention-deficit/hyperactivity disorder:
brain imaging, molecular genetic and environmental factors and the
dopamine hypothesis. Neuropsychol Rev. 17:39–59. 2007. View Article : Google Scholar
|
|
40.
|
Yoon DY, Rippel CA, Kobets AJ, et al:
Dopaminergic polymorphisms in Tourette syndrome: association with
the DAT gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet.
144B:605–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Bannon MJ: The dopamine transporter: role
in neurotoxicity and human disease. Toxicol Appl Pharmacol.
204:355–360. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Kurian MA, Zhen J, Cheng SY, et al:
Homozygous loss-of-function mutations in the gene encoding the
dopamine transporter are associated with infantile
parkinsonism-dystonia. J Clin Invest. 119:1595–1603.
2009.PubMed/NCBI
|
